ABCA3 p.Glu292Val
c.875A>T · rs149989682 · VCV203381
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7033 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.949 | strongly pathogenic-leaning |
| SaProt | LLR -7.95 | tolerated |
| ⇒ AlphaMissense and REVEL call this damaging; SaProt does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.8 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 40 kb · p 0.47 · regional, not allelic |
| Overall | ||
| CADD | 31.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 1.75% | 57 |
| European (non-Finnish)grpmax | 0.579% | 173 |
| Remaining individualsnot grpmax-eligible | 0.386% | 259 |
| Admixed American | 0.172% | 583 |
| African / African-American | 0.0959% | 1,043 |
| Finnishnot grpmax-eligible | 0.0719% | 1,392 |
| Middle Eastern | 0.0166% | 6,040 |
| South Asian | 0.00659% | 15,181 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00338% | 29,600 |
| East Asian | 0.00223% | 44,872 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ABCA3
- Protein
- p.Glu292Val
- Coding
- c.875A>T
- MANE Select
- NM_001089
- dbSNP
- rs149989682
- Type
- single nucleotide variant
- Location
- chr16:2317763 (GRCh38)
- Gene constraint
- LOEUF 0.612 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 81.00 · 2 PDB
- Residue 292
- a UniProt-annotated variant site (in smdp3; uncertain significance; does not affect lamellar bodies membrane location; does not affect proteolytic cleavage; affects lamellar bodies formation; does not affect cholesterol and phosphatidylcholine transport; decreases vesicles formation; does not affect free cholesterol induced cell death); an α-helix
Disease context
Also linked: hereditary pulmonary alveolar proteinosisinterstitial lung disease due to ABCA3 deficiencyinterstitial lung disease 2
Similar variants
- ABCA3 c.1112-20G>A Likely pathogenic ★★ same condition
- ABCA3 c.2053-1G>C Likely pathogenic ★★ same condition
- ABCA3 c.2414+1G>A Likely pathogenic ★★ same condition
- ABCA3 c.3863-98C>T Pathogenic ★★ same condition
- ABCA3 c.614-2A>G Likely pathogenic ★★ same condition
- ABCA3 p.Ala1070Thr Likely pathogenic ★★ ⚠ same condition
- ABCA3 p.Arg1550Trp Likely pathogenic ★★ same condition
- ABCA3 p.Arg155Trp Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/abca3-p-glu292val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown